Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.

Slični predmeti

• Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.
  od: Khatami, A, i dr.
  Izdano: (2012)
• Demonstration of immunologic memory using serogroup C meningococcal glycoconjugate vaccine.
  od: Snape, MD, i dr.
  Izdano: (2009)
• Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
  od: Snape, MD, i dr.
  Izdano: (2006)
• Serogroup c meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
  od: Snape, M, i dr.
  Izdano: (2006)
• A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
  od: Pace, D, i dr.
  Izdano: (2008)